Ecological validity of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients
CONCLUSIONS: The MoCA is a valid estimate of daily-life functional autonomy in non-demented PD patients, also reflecting apathetic features of a dysexecutive nature.PMID:37482058 | DOI:10.1159/000532115 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - July 23, 2023 Category: Neurology Authors: Edoardo Nicol ò Aiello Alfonsina D'Iorio Federica Solca Silvia Torre Eleonora Colombo Alessio Maranzano Alberto De Lorenzo Valerio Patisso Mauro Treddenti Claudia Morelli Alberto Doretti Luca Maderna Federico Verde Roberta Ferrucci Sergio Barbieri Fabian Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
CSF A β40 levels do not correlate with the clinical manifestations of Alzheimer's Disease
Conclusion In this study, we found no significant differences in clinical symptoms or disease progression in AD patients according to their CSF Aβ40 concentration. Aβ40 was positively correlated with p-Tau and total Tau concentrations, supporting their potential interaction in AD pathophysiology.PMID:37231965 | DOI:10.1159/000530907 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - May 26, 2023 Category: Neurology Authors: Jes ús Garcia Castro Helena M éndez Del Sol Olaia Rodr íguez Fraga Mar ía Hernández Barral Soledad Serrano L ópez Ana Frank Garc ía Ángel Martín Montes Source Type: research
